CVD

Clinicians Report Priority for Participants Has Shifted to Disease Management in Post-Pandemic Period

Retrieved on: 
Monday, March 27, 2023
Blood pressure, Obesity, Depression, Diabetes, Health education, Anxiety, Overalls, Cardiovascular disease, Health, Registered, CVD, Cardiology, Language, A1C, Patient, American Association of Clinical Endocrinologists, Mental health, Conditional sentence, Pharmaceutical industry, Nursing

NEW YORK, March 27, 2023 /PRNewswire-PRWeb/ -- Cecelia Health has released results from a survey of over 100 of their clinicians revealing how a post-pandemic period where most daily activities are returning to normal is impacting chronic disease management. The survey asked clinicians to answer questions about their recent interactions with program participants who live with cardiometabolic conditions including cardiovascular disease (CVD), diabetes, and obesity.

Key Points: 
  • The survey asked clinicians to answer questions about their recent interactions with program participants who live with cardiometabolic conditions including cardiovascular disease (CVD), diabetes, and obesity.
  • "In 2021, our clinicians saw discussions around mental health issues like depression and anxiety take priority over discussions about disease management itself.
  • However, as we begin to emerge from the pandemic, more patients are now making disease management a high priority in their lives," said Mark Clermont, chief executive officer at Cecelia Health.
  • More than three-quarters of clinicians (78%) believe the use of telehealth will continue to grow as a resource for chronic condition management throughout 2023.

Cell Culture Protein Surface Coatings Global Market Report 2023: Growing Interest of Scientists and Biotechnology Companies in Stem Cell Research Boosts Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 22, 2023
Health, Biotechnology, CVD, Insulin, T cell deficiency, Corning Inc., Prevalence, Diabetes, 3D, Cancer, Molecular Devices, Research, Cell, Gelatin, USD, DSM-IV codes, 2D, Government, Incidence, Animal, Drug discovery, Growth, Cell engineering, Region, A-DNA, Cell adhesion, Protein Source of the Future...Now!, Vaccine, Dietary supplement, Fine chemical

The "Cell Culture Protein Surface Coatings Market by Coating (Self-coating, Pre-coating), by Protein Source, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Culture Protein Surface Coatings Market by Coating (Self-coating, Pre-coating), by Protein Source, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
  • Increasing advancements in the research and development field, growing interest of scientists and biotechnology companies in stem cell research, rising demand of cell culture protein surface coating provides improved development and cell adhesion in in-vitro cell culture are some of the factors contributing to the market growth.
  • However, prohibitions against the use of protein coating materials derived from animals and the high cost of cell culture protein surface coatings products is expected to hinder the growth.
  • In 2022, North America region accounted for the highest revenue in the cell culture protein surface coatings market during the forecast period.

PocDoc announces £2.5M extension to Seed round, adds Simplyhealth Ventures to investors

Retrieved on: 
Wednesday, March 22, 2023
UK Health Alliance on Climate Change, Interview, TAG Heuer, Cardiovascular disease, CVD, McLaren, Security, Death, Diagnosis, Mortality, NHS, Environment, Oak Investment Partners, Chair, Cryptocurrency, Health insurance, Pharmaceutical industry

This extension round was led by existing investors Forward Partners and MMC Ventures and sees Simplyhealth Ventures join alongside notable angel investors including founders of Graze and Skin + Me and the owners of Mclaren and TAG Heuer.

Key Points: 
  • This extension round was led by existing investors Forward Partners and MMC Ventures and sees Simplyhealth Ventures join alongside notable angel investors including founders of Graze and Skin + Me and the owners of Mclaren and TAG Heuer.
  • Keith has extensive experience in healthcare and his commercial expertise will supercharge the company's already impressive commercial growth.
  • PocDoc is initially focusing initially on cardiovascular disease, where access to full 5 marker cholesterol testing is a major obstacle to diagnosis and treatment.
  • Bruce Macfarlane, Managing Partner of MMC Ventures, says "PocDoc has made excellent progress in achieving regulatory approvals – a major inflexion point for unlocking growth.

CVD Equipment to Announce 2022 Fourth Quarter and Year End Results

Retrieved on: 
Monday, March 20, 2023
Oil, Gas, Alternative Energy, Batteries, Energy, Technology, Other Manufacturing, Semiconductor, Engineering, Nanotechnology, Chemicals, Plastics, Automotive Manufacturing, Aerospace, Manufacturing, International, CVD, Digital Equipment Corporation, CVV, Eastern Time Zone

CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition systems, announced today that it will release its 2022 fourth quarter and year end results after markets close on Monday, March 27, 2022.

Key Points: 
  • CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition systems, announced today that it will release its 2022 fourth quarter and year end results after markets close on Monday, March 27, 2022.
  • CVD Management will hold a conference call to discuss its results at 5:00 pm (Eastern Time) that day.
  • To participate in the live conference call, please dial toll free (877) 407-2991 or International (201) 389-0925.
  • The archived webcast will be available at the same location approximately two hours following the end of the live event.

CO2 Medical Laser Systems Global Market Report 2023: Growing Demand for Cosmetic Dentistry and Aesthetic Procedures Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Monday, March 20, 2023
Health, Dental, Medical Devices, Dentistry, Infection, Blepharoplasty, United States National Library of Medicine, Stent, Gynaecology, US Foods, Obesity, National Centre for Infectious Diseases, Bleeding, IgG4-related ophthalmic disease, Prevalence, Diabetes, Dermatitis, Food, NCBI, Cardiovascular disease, Skin, Woman, National Center for Biotechnology Information, CVD, Polycystic ovary syndrome, USD, Heart, American Society of Plastic Surgeons, National library, Dermatology, Laser, Urology, Developed country, Application, PCOS, Ophthalmology, Oral hygiene, Conditional sentence, Growth, Region, Plastic, FDA, Neurology, CO2, World Health Organization, Medical device, Health care, Veterinary medicine, Pharmaceutical industry

The "CO2 Medical Laser Systems Market by Type, by Application, by End User, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "CO2 Medical Laser Systems Market by Type, by Application, by End User, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
  • Increasing healthcare spending, growing demand for cosmetic dentistry and improved aesthetic appearance, and adoption of technological advancements are other factors supporting the market growth.
  • The number of CVD-related preventive and therapeutic procedures has increased recently, which has boosted demand for CO2 laser cutting equipment.
  • In 2022, North America region accounted for the highest revenue in the CO2 medical laser market during the forecast period.

Aluminum Association Requests Ruling that Certain Imports from Korea are Circumventing Unfair Trade Orders on Common Alloy Aluminum Sheet from China

Retrieved on: 
Thursday, March 16, 2023
CAAS, The Aluminum Association, Office of Inspector General, U.S. Department of Health and Human Services, Working Group, Commerce Department trade mission controversy, Aluminium, Common, Active Measures Working Group, CVD, Kelley Drye & Warren, AD, U.S. Department of Commerce Office of Security, United States Department of Commerce, Commerce, Cryptocurrency, Recycling

“We urge the Commerce Department to take action promptly to enforce our trade laws against efforts by a Chinese producer and its Korean affiliate to evade the unfair trade orders on common alloy aluminum sheet from China,” said Charles Johnson, president and CEO of the Aluminum Association.

Key Points: 
  • “We urge the Commerce Department to take action promptly to enforce our trade laws against efforts by a Chinese producer and its Korean affiliate to evade the unfair trade orders on common alloy aluminum sheet from China,” said Charles Johnson, president and CEO of the Aluminum Association.
  • The aluminum sheet at issue includes both unclad aluminum sheet, as well as multi-alloy, clad aluminum sheet.
  • In February 2019, the Commerce Department published antidumping and countervailing (AD/CVD) orders on imports of CAAS from China following an action by the Aluminum Association’s Common Alloy Aluminum Sheet Trade Enforcement Working Group.
  • Since those orders were published, U.S. imports of aluminum sheet from China have declined substantially.

Mammalian Polyclonal IgG Antibody Global Market Report 2023: Growing Prevalence of Standard Laboratory Tests Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 16, 2023
Biotechnology, Science, Health, Research, Neoplasm, Syphilis, Prevalence, Antibody, Immunoelectrophoresis, Organization, Epitope, Immunoglobulin G, Conditional sentence, University, Human, COVID-19, IHC, AIDS, Flow cytometry, Immunohistochemistry, Cancer, Hospital, CVD, Government, Anemia, Growth, GSK plc, Viral, Government agency, Acceleration, ELISA, Lyme disease, Mouse, Plasma, Application, Biomarker, Agilent Technologies, USD, Region, Diagnosis, CDC, Western blot, Rabbit, Serum, Autoimmunity, SARS-CoV-2, State, Investment, GenScript Biotech, Animal, Disease, Chip, Incidence, Diabetes, Fine chemical, Pharmaceutical industry, Vaccine, Immunoprecipitation

The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
  • The mammalian polyclonal IgG antibody market size is estimated to be USD 1,347.4 million in 2022 and is expected to witness a CAGR of 5.28% during the forecast period 2023-2033.
  • Furthermore, growing prevalence of standard laboratory tests, government investment, acceleration in institutional and academic research, and affordability of supporting equipment and technology are other factors supporting the market growth.
  • Growing prevalence of standard laboratory tests such as microarray assays, western blot analysis, immunohistochemical, and cell imaging is predicted to propel the mammalian polyclonal IgG antibody market growth during the forecast period.

Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk

Retrieved on: 
Wednesday, March 8, 2023
History, Mortality, Phase 3, Circulatory system, CMO, Follicle-stimulating hormone, Prostate cancer, Cardiovascular disease, Death, Standard of care, Cancer, ADT, CVD, FDA, Principal Scientific Adviser to the Government of India, Hormone, Breast, Bray, Pituitary gland, Patient, Disease, GenesisCare, Follicle, Prostate, Treatment, MACE, Personalized medicine, American Heart Association, Testosterone, Incidence, Prevalence, Androgen deprivation therapy, Luteinizing hormone, Gonadotropin-releasing hormone, US Foods, Risk, Pharmaceutical industry, Medical imaging, Birth control, Ernst Antevs

Up to 30% of advanced prostate cancer patients on Androgen Deprivation Therapy have pre-existing Cardiovascular Disease.

Key Points: 
  • Up to 30% of advanced prostate cancer patients on Androgen Deprivation Therapy have pre-existing Cardiovascular Disease.
  • This would be the first Phase 3 trial for a specific label to treat prostate cancer in patients with increased cardiovascular risk, addressing a significant need for prostate cancer drugs with a better cardiac toxicity profile.
  • Teverelix, a decapeptide, has the potential to be the first hormone therapy specifically approved to treat advanced prostate cancer patients with a history of cardiovascular disease.
  • “We are delighted to reach this critical milestone in Antev’s journey to secure regulatory guidance to develop Teverelix in advanced prostate cancer patients with increased cardiovascular risk,” commented Amit Kohli, Chief Executive Officer of Antev.

Global Lab Grown Diamond Market Report 2023: Fall in Prices of Lab Grown Diamonds Bolsters Demand - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 9, 2023
Chemicals, Plastics, Manufacturing, Diamond, FTC, Generation, Electronics, Laser, Generation Z, Quantum computing, Application, Artificial intelligence, Acquisition, Biotechnology, Growth, HPHT, Mining, Sale, CVD, Semiconductor, Jewellery, Federal Trade Commission, The Nader Report on the Federal Trade Commission, LGD, COVID-19, Urbanization, Telephone numbers in Hungary, Nature, Organization, Video game, Gemstone, Retail

Colored lab grown diamond market is the fastest growing segment of global lab grown diamond market owing to increasing number of companies trading in fancy colored diamonds, rapidly expanding fashion industry, rising popularity of colored diamond jewelry among millennials & gen Z, urbanization, rising demand of extravagant colored lab grown diamonds in haute couture and the prestige, royalty & status associated with owing colored diamonds.

Key Points: 
  • Colored lab grown diamond market is the fastest growing segment of global lab grown diamond market owing to increasing number of companies trading in fancy colored diamonds, rapidly expanding fashion industry, rising popularity of colored diamond jewelry among millennials & gen Z, urbanization, rising demand of extravagant colored lab grown diamonds in haute couture and the prestige, royalty & status associated with owing colored diamonds.
  • Asia Pacific lab grown diamond market is divided into five regions on the basis of geographical operations, namely, China, Japan, India, South Korea and Rest of Asia Pacific, where China lab grown diamond market held the largest share in Asia Pacific lab grown diamond market owing to rapidly growing middle class, followed by India.
  • The global lab grown diamond market has been growing over the past few years, due to factors such as rapid urbanization, fall in prices of lab grown diamonds, increasing demand from end user industries, fast growing jewelry industry, rising demand for lab grown diamonds among millennials, etc.
  • So, increasing demand from various end user industries will continue to boost the growth of global lab grown diamond market.

Cell Therapy Technologies Global Market Report 2023: Sector to Reach $7.39 Billion by 2027 at a 14.9% CAGR - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 9, 2023
Health, Biotechnology, Benchmark, Regenerative medicine, Research, Tisagenlecleucel, California Institute for Regenerative Medicine, Lonza, Growth, Pressure, Hitachi, Cardiovascular disease, Clinical trial, Intelligence, CAR, GDP, Radiation, CVD, Patient, Cancer, Create, Government, Investment, Otorhinolaryngology, CIRM, COVID-19, Agriculture, Pharmaceutical industry, Video game, Fine chemical, Marketing

The "Cell Therapy Technologies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Therapy Technologies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • North America was the largest region in the cell therapy technologies market in 2022.
  • The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market.